Myriad Genetics
Quarterly Financials
| Values in thousands | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 |
|---|---|---|---|---|
Revenue | $211,500 | $202,200 | $196,600 | $191,900 |
Gross Profit | 147,100 | 137,600 | 135,000 | 134,300 |
EBITDA | -46,100 | |||
EBIT | -60,200 | |||
Net Income | -36,700 | -26,000 | -31,200 | -61,300 |
Net Change In Cash | 211,500 | 202,200 | 196,600 | 191,900 |
Free Cash Flow | -6,300 | -27,200 | -68,200 | -39,600 |
Cash | 92,400 | 96,900 | 132,100 | 76,000 |
Basic Shares | 90,900 | 90,500 | 89,900 | 81,900 |
Annual Financials
| Values in thousands | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|
Revenue | $753,200 | $678,400 | $690,600 | $557,000 |
Gross Profit | 517,000 | 476,400 | 493,000 | 378,800 |
EBITDA | -67,800 | 14,100 | -123,400 | |
EBIT | -123,700 | -48,700 | -194,800 | |
Net Income | -263,300 | -112,000 | -27,200 | -223,700 |
Net Change In Cash | 753,200 | 678,400 | 690,600 | 557,000 |
Cost of Revenue | 70,500 | |||
Free Cash Flow | -184,200 | -151,600 | 200 | 75,100 |
Cash | 132,100 | 56,900 | 258,400 | 117,000 |
Basic Shares | 89,900 | 80,600 | 78,000 | 74,775 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-09-30 | $0.06 |
2024-06-30 | $0.05 |
2024-03-31 | -$0.01 |
2023-12-31 | $0.04 |
